<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Matrix metalloproteinases (MMPs) and cysteine proteases (calpain and cathepsin B) play an important role in cell <z:hpo ids='HP_0011420'>death</z:hpo> and are upregulated after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Because there is a significant interaction between MMP-9 with calpain and cathepsin B, we investigated the role of E64d (a calpain and cathepsin B inhibitor) on MMP-9 activation in the rat focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> model </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Male Sprague-Dawley rats were subjected to 2 hours of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> by using the suture insertion method followed by 22 hours of reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>In the treatment group, a single dose of E64d (5 mg/kg IP) was administrated 30 minutes before the induction of focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, whereas the nontreatment group received <z:chebi fb="0" ids="28262">dimethyl sulfoxide</z:chebi> only </plain></SENT>
<SENT sid="4" pm="."><plain>The neurological deficits, <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes, Evans blue extravasation, <z:hpo ids='HP_0002181'>brain edema</z:hpo>, and MMP-9 activation in the brain were determined </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Pretreatment with E64d produced a significant reduction in the <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> volume (353.1+/-19.8 versus 210.3+/-23.7 mm3) and the neurological deficits </plain></SENT>
<SENT sid="6" pm="."><plain>Immunofluorescence studies showed MMP-9, calpain, and cathepsin B activation colocalized to both neurons and the neurovascular endothelial cells after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, which was reduced by E64d </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: These results suggest that E64d treatment provides a neuroprotective effect to rats after transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> by inhibiting the upregulation of MMP-9 </plain></SENT>
</text></document>